Ion Exchange India Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is SODIUM POLYSTYRENE SULFONATE USP (INDION 254), with a corresponding US DMF Number 18364.
Remarkably, this DMF maintains an Active status since its submission on May 16, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 07, 2014, and payment made on November 18, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II